Emergency Neurological Life Support: Pharmacotherapy

被引:15
作者
Brophy, Gretchen M. [1 ,2 ]
Human, Theresa [3 ]
Shutter, Lori [4 ]
机构
[1] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA
[3] Washington Univ, Barnes Jewish Hosp, Dept Clin Pharm, St Louis, MO USA
[4] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Dept Neurol & Neurosurg, Pittsburgh, PA USA
关键词
ENLS; Pharmacotherapy; Medication; Adverse drug event; Drug interaction; PROTHROMBIN COMPLEX CONCENTRATE; HEALTH-CARE PROFESSIONALS; ACTIVATED FACTOR-VII; HYPERTONIC SALINE; EXCESSIVE ANTICOAGULATION; ANTIFIBRINOLYTIC THERAPY; REVERSAL; GUIDELINES; MANAGEMENT; MANNITOL;
D O I
10.1007/s12028-015-0158-1
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The appropriate use of medications during Emergency Neurological Life Support (ENLS) is essential to optimize patient care. Important considerations when choosing the appropriate agent include the patient's organ function and medication allergies, potential adverse drug effects, drug interactions, and critical illness and aging pathophysiologic changes. Critical medications used during ENLS include hyperosmolar therapy, anticonvulsants, antithrombotics, anticoagulant reversal and hemostatic agents, anti- shivering agents, neuromuscular blockers, antihypertensive agents, sedatives, vasopressors and inotropes, and antimicrobials. This article focuses on the important pharmacokinetic and pharmacodynamics characteristics, advantages and disadvantages, and clinical pearls of these therapies, providing practitioners with essential drug information to optimize pharmacotherapy in acutely ill neurocritical care patients.
引用
收藏
页码:S48 / S68
页数:21
相关论文
共 55 条
  • [1] [Anonymous], 2015, LEX COMP IL D
  • [2] [Anonymous], 2013, LEX COMP IL D
  • [3] Predictors and clinical implications of shivering during therapeutic normothermia
    Badjatia, Neeraj
    Kowalski, Robert G.
    Schmidt, J. Michael
    Voorhees, Marc E.
    Claassen, Jan
    Ostapkovich, Noeleen D.
    Presciutti, Mary
    Connolly, E. Sander
    Palestrant, David
    Parra, Augusto
    Mayer, Stephan A.
    [J]. NEUROCRITICAL CARE, 2007, 6 (03) : 186 - 191
  • [4] Metabolic Impact of Shivering During Therapeutic Temperature Modulation The Bedside Shivering Assessment Scale
    Badjatia, Neeraj
    Strongilis, Evangelia
    Gordon, Errol
    Prescutti, Mary
    Fernandez, Luis
    Fernandez, Andres
    Buitrago, Manuel
    Schmidt, J. Michael
    Ostapkovich, Noeleen D.
    Mayer, Stephan A.
    [J]. STROKE, 2008, 39 (12) : 3242 - 3247
  • [5] Guidelines on oral anticoagulation (warfarin): third edition - 2005 update
    Baglin, TP
    Keeling, DM
    Watson, HG
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (03) : 277 - 285
  • [6] Prothrombin Complex Concentrates for Oral Anticoagulant Therapy-Related Intracranial Hemorrhage: A Review of the Literature
    Bershad, Eric M.
    Suarez, Jose I.
    [J]. NEUROCRITICAL CARE, 2010, 12 (03) : 403 - 413
  • [7] Recombinant activated factor VII for acute subdural haematoma in an elderly patient taking fondaparinux
    Bordes, J.
    Asencio, Y.
    Kenane, N.
    Fesselet, J.
    Meaudre, E.
    Goutorbe, P.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2008, 101 (04) : 575 - 576
  • [8] Low-dose vitamin K therapy in excessively anticoagulated patients: A dose-finding study
    Brophy M.T.
    Fiore L.D.
    Deykin D.
    [J]. Journal of Thrombosis and Thrombolysis, 1997, 4 (2) : 289 - 292
  • [9] Guidelines for the Evaluation and Management of Status Epilepticus
    Brophy, Gretchen M.
    Bell, Rodney
    Claassen, Jan
    Alldredge, Brian
    Bleck, Thomas P.
    Glauser, Tracy
    LaRoche, Suzette M.
    Riviello, James J., Jr.
    Shutter, Lori
    Sperling, Michael R.
    Treiman, David M.
    Vespa, Paul M.
    [J]. NEUROCRITICAL CARE, 2012, 17 (01) : 3 - 23
  • [10] Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed?
    Crawford, JH
    Augustson, BM
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2006, 184 (07) : 365 - 366